I understand the confusion! I just posted a question myself about DMD's. My neuro was adamant that i should try Tecfidera (which i did but couldn't last out the side effects) so now we'll try Gilenya, these are both tablet forms. I feel confused about it all but i don't feel i need to choose a drug as my neuro seems confident with his recommendations so i feel confident to follow them.
The first year is such a roller coaster, as soon as you think your over the first hump another one comes out of nowhere. I hope you find some clarity about which one to take, I'm afraid i don't know much about the injectables (although i will if i can't handle these tablets too). Best of luck.
Jane x
All the information is scary. You have to remember when they do clinical trials they have to list every illness a participant gets even if it had nothing to do with the drugs. It is all benefit:risk ratio.
The second thing to understand is slowing progression is key with MS. You can have progression with or with out symptoms. You can't wait until you have damage and then get on a DMD and go back to the way you were before the damage.
They did not have DMDs when I got MS in the 1960's. All of my MS symptoms are permanent, I got so many permanent MS Symptoms as a child that I do not know what is abnormal. To me double vision is normal.
I am now going on my 6th regiment of chemo. Most of the chemos have not had that bad of side effects as were listed. No body in there right mind would sign up for these side effects. They are worse than MS drugs but then my cancer is worse in some ways than MS.
Also choosing a DMD says this is a really serious illness I am facing. That has a lot to do with DMDs being scary. It is no longer theoretical..
Alex
Impressive that your neuro is willing to push for the most effective DMDs for you! Mine really didn't give an opinion. It was 100% up to me (like I have any clue about these things....).
Good luck with your decision. Let us know what you decide & how it is going for you.
Cheryl
Hi, Thank you both so much for the information & advice.
I've made phone call today to arrange meeting with my MS specialist nurse to go through any concerns I have.
Lots of reading & gathering information for me!
Thankyou both again, much appreciated. Take care
T
As Immie mentioned, both Lemtrada and Tysabri are monoclonal antibodies (MAB). Both are delivered via IV infusion. Tysabri is given monthly. Lemtrada is given over 5 consecutive days and then not for another year. I get a 3rd MAB called Rituxan. It’s given via IV every 6-12 months.
All 3 of these drugs are a step up from the typical first DMDs like Copaxone, Ribif, Avonex and Betaseron. Rixtuxan may be two steps up. This is what your doc may mean when it’s best to start low and leave room to move high. I started on Tysabri. After 20 monthly infusions it stopped working so I moved up to Rituxan. That was 2 years ago and the Rituxan is still working.
None of the DMDs are without risk. In some cases the risk is serious. The frequency of administration is another factor to consider. The deciding factor may be efficacy. These are all things that you should talk about with your doc and then make the choice that works best for you.
Kyle
They're both monoclonal antibodies, which is a class of drugs both Kyle (kwarendorf) and I are on (though we're on ones you've not listed here). This is the newer, more effective generation of drugs to modify MS. It's my understanding that both are given via monthly infusion? In these senses, they're fairly similar in terms of how they work and how you take them.
If I were in your shoes, the thing I'd be thinking about is published safety and efficacy data; compare and contrast. I'd likely go for Tysabri simply because it's been on the market for a longer time. There's likely more awareness of risks and there may be some more longitudinal data coming out. But this is just me teasing out what would be going through my head in your situation.
It's a tough, important decision which DMDs to take. It's definitely mentally exhausting. But on the upside, many many people can only wish their neurologists are on board for more aggressive treatments from day one.